510(k) Report

510(k) · Cleared

Cleared

QuadraSphere Microspheres

K151187510(k) TraditionalCleared Jul 27, 201584-day reviewClass II21 CFR 870.3300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biosphere Medical, S.A. · KRD Device, Vascular, For Promoting Embolization

Cleared on Jul 27, 2015 as substantially equivalent to K052742 (Biosphere Medical, Inc., 2006) and 1 other predicate after an 84-day review. Its family tree reaches back 6 generations to 2001.

Decided
Jul 27, 2015
Review
84 days
Class
Class II
Product code
KRD
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K010026 (2001). 13 ancestors in all, the oldest K871047 (1987). No later device cites it as a predicate yet.

  1. Root · 6 generations backK010026 Embogold MicrosphereBiosphere Medical, Inc. · 2001
  2. 5 generations backK023089 Gelspheres Embolic AgentBiocure, Inc. · 2002
  3. 4 generations backK033761 Gelspheres / Beadblock Compressible MicrospheresBiocompatibles UK Limited · 2004
  4. 3 generations backK042231 Gelspheres Microspheres and Bead Block Compressible MicrospheresBiocompatibles UK Limited · 2004
  5. 2 generations backK052742 Hepasphere MicrospheresBiosphere Medical, Inc. · 2006
  6. 1 generation backK113822 Quadrasphere 30 to 60Biosphere Medical, Inc. · 2012
  7. This deviceK151187 QuadraSphere MicrospheresBiosphere Medical, S.A. · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K010026Embogold MicrosphereBiosphere Medical, Inc.2001—
−5K023089Gelspheres Embolic AgentBiocure, Inc.2002—
−4K033761Gelspheres / Beadblock Compressible MicrospheresBiocompatibles UK Limited2004—
−3K042231Gelspheres Microspheres and Bead Block Compressible MicrospheresBiocompatibles UK Limited2004—
−2K052742Hepasphere MicrospheresBiosphere Medical, Inc.2006—
−1K113822Quadrasphere 30 to 60Biosphere Medical, Inc.2012—
0 (this device)K151187QuadraSphere MicrospheresBiosphere Medical, S.A.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199410
199610
199710
200010
200210
200310
FIG. 1 — Lineage of K151187, 2001–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KRD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KRD device

  1. #1 K253511 Concerto Versa™ Detachable Coilscore 17.6 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K052742Hepasphere Microspheres
Summary page 4
…Name: Vascular Embolization Device Manufacturer: BioSphere Medical S.A. Premarket Notification: K052742, cleared Nov 7, 2006 Predicate Device Premarket Notification Predicate…
Biosphere Medical, Inc.2006—
*K113822Quadrasphere 30 to 60
Summary page 4
…Neurovascular Embolization Device Manufacturer: BioSphere Medical S.A. Premarket Notification: K113822, cleared Feb 6, 2012 CONFIDENTIAL INFORMATION…
Biosphere Medical, Inc.2012—

Also cleared against K052742: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 4 companies; a new generation was cleared every 2.0 years on median.
  • None of the 13 ancestors has a recall.
  • 2 other devices also cite its predicate K052742.

How does its category compare?

All KRD devices

KRD Device, Vascular, For Promoting Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · KRD

9in 2025

2007: 22008: 52009: 42010: 32011: 52012: 82013: 112014: 72015: 112016: 42017: 42018: 42019: 62020: 42021: 32022: 82023: 22024: 62025: 92026 (partial year): 7
2007high 11 (2013) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KRD

60in 2025

2008: 84 days median2009: 27 days median2010: 150 days median2011: 36 days median2012: 30 days median2013: 33 days median2014: 134 days median2015: 130 days median2016: 164 days median2017: 89 days median2018: 62 days median2019: 178 days median2020: 137 days median2021: 134 days median2022: 175 days median2024: 70 days median2025: 60 days median2026 (partial year): 70 days median
2007high 178 (2019) · low 27 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KRD

1in 2024

2010: 12013: 12023: 12024: 12026 (partial year): 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KRD

1,572in 2025

2007: 212008: 142009: 402010: 612011: 1022012: 1372013: 2442014: 1592015: 3372016: 4372017: 7362018: 1,0662019: 1,1852020: 1,1672021: 1,4442022: 1,4982023: 1,3712024: 1,5352025: 1,572
2007high 1,572 (2025) · low 14 (2008)2025

MAUDE reports naming product code KRD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—021
2008584014
2009427040
20103150161
20115360102
20128300137
201311331244
201471340159
2015111300337
201641640437
20174890736
201846201,066
2019617801,185
2020413701,167
2021313401,444
2022817501,498
20232—11,371
202467011,535
202596001,572
20267701—

What is it indicated for?

QuadraSphere Microspheres are indicated for embolization of hypervascularized tumors including hepatoma, and peripheral arteriovenous malformations.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K151187: QuadraSphere Microspheres.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151187

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026